Overview
Epithalon (also known as Epitalon) is a synthetic tetrapeptide commonly utilised in laboratory research involving peptide structure, cellular signalling pathways, and pineal gland–related studies. Epithalon is a peptide composed of the amino acid sequence Ala-Glu-Asp-Gly, originally identified through research involving the pineal gland.
In controlled research environments, it is used as a model compound in studies examining peptide interactions, cellular processes, and experimental biological systems.
Chemical reference information: CAS number: 307297-39-8; Molecular formula: C₁₄H₂₂N₄O₉; Molecular weight: 390.35 g/mol; Sequence: Ala-Glu-Asp-Gly. These reference identifiers describe the formulation; the batch-specific analytical record identifies the supplied material.
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.
Epithalon 10 mg is offered as a NORVEXA research pen. The selected strength refers to the compound content of this pen reference. Request the matching batch record for identity, analytical specifications, and presentation details.
Handling and storage
Reference conditions for unreconstituted research material are −20°C with moisture and direct light excluded. Use the storage instructions on the supplied batch record for the actual presentation, and record any change of physical state or storage conditions.
Where laboratory preparation is required, use an appropriate validated solvent and aseptic peptide-handling procedure. Solvent compatibility, final concentration, and post-preparation storage depend on the specific formulation and experimental protocol. The catalog strength is the compound amount, not the concentration of a prepared solution.
NORVEXA Bioscience batch documentation can be requested using the printed reference and lot number. Review identity, analytical purity, presentation, and handling specifications before including a material in a laboratory workflow.